These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 21480881

  • 1. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
    Alvarez V, Januel JM, Burnand B, Rossetti AO.
    Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levetiracetam versus phenytoin in management of status epilepticus.
    Chakravarthi S, Goyal MK, Modi M, Bhalla A, Singh P.
    J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
    [Abstract] [Full Text] [Related]

  • 8. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
    Misra UK, Kalita J.
    Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C, Rubio G.
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonconvulsive status epilepticus on treatment with levetiracetam.
    Atefy R, Tettenborn B.
    Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determinants of success in the use of oral levetiracetam in status epilepticus.
    Rossetti AO, Bromfield EB.
    Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
    [Abstract] [Full Text] [Related]

  • 16. Levetiractam in the treatment of two children with myoclonic status epilepticus.
    Haberlandt E, Sigl SB, Scholl-Buergi S, Karall D, Rauchenzauner M, Rostásy K.
    Eur J Paediatr Neurol; 2009 Nov; 13(6):546-9. PubMed ID: 19010072
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K, Inokuchi R, Daidoji H, Naraba H, Sonoo T, Hashimoto H, Tokunaga K, Hiruma T, Doi K, Morimura N.
    Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
    [Abstract] [Full Text] [Related]

  • 20. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S, Grumbt M, Müller M, Schulze A.
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.